COVID-19 Research in Brief: 11 April to 17 April, 2020
16/04/2020 por Tatu D'OqueiThe US company Inovio Pharmaceuticals launched a phase I clinical trial of INO-4800, its DNA vaccine for COVID-19.
The US company Inovio Pharmaceuticals launched a phase I clinical trial of INO-4800, its DNA vaccine for COVID-19.